ASPEN Book Corrections and Updates
We at ASPEN make every effort to present current, accurate information, but typographical and other errors do occur. All errors are corrected in the next print run following discovery. The following corrections may have already been made in the printing you have purchased. If you find an error that is not already listed, you can report it here.
ASPEN Pediatric Nutrition Support Core Curriculum, Third Edition
- Page 693, Table 33-2. Comparison of Commercially Available Pediatric Amino Acid Products. All numerical data under Amino acid content (g/100mL) should be shifted up by one row. Table with correction is below.
| Company | B. Braun | ICU Medical | Baxter |
| Product | TrophAmine | Aminosyn PF | Premasol |
| Introduction date (FDA approval date) | July 20, 1984 | Sept. 6, 1985 | June 23, 2003 |
| Amino acid content (g/100 mL) | |||
| Isoleucine | 0.820 | 0.760 | 0.820 |
| Leucine | 1.400 | 1.200 | 1.400 |
| Lysine | 0.820 | 0.677 | 0.820 |
| (added as lysine acetate) | 1.200 | — | — |
| Methionine | 0.340 | 0.180 | 0.340 |
| Phenylaline | 0.480 | 0.427 | 0.480 |
| Threonine | 0.420 | 0.512 | 0.420 |
| Tryptophan | 0.200 | 0.180 | 0.200 |
| Valine | 0.780 | 0.673 | 0.780 |
| Cysteine | <0.016 | — | <0.016 |
| (as cysteine HCI H2O) | <0.024 | — | — |
| Histidine | 0.480 | 0.312 | 0.480 |
| Tyrosine | 0.240 | 0.044 | 0.240 |
| (added as tyrosine) | 0.044 | — | — |
| (added as N-acetyl-L-tyrosine) | 0.240 | — | — |
- Page 698, Table 33-7. The content of footnotes b and c should be switched. Corrected version below:
Table 33-7. Pediatric Trace Element Requirementsa
| Trace element | Preterm neonates <3 kg (mcg/kg/d) | Term neonates 3–10 kg (mcg/kg/d) | Children 10–40 kg (mcg/kg/d) | Adolescents >40 kg/d |
| Zinc | 500b | 50-250 | 50-125 | 2–5 mg |
| Copper | 40 | 20 | 5-20 | 200–500 mcg |
| Manganesec | 1 | 1 | 1 | 40–100 mcg |
| Chromiumc | 0.05-0.2 | 0.2 | 0.14-0.2 | 5–15 mcg |
| Seleniumb | 7 | 2 | 1-2 | 40–60 mcg |
a Assumes normal organ function and losses.
b Commercially available multi-trace element products will not meet needs; additional supplementation required with single entity products.
c Consider removing from PN since adequate amounts provided through contamination of other additives.
The ASPEN Adult Support Core Curriculum, Third Edition
- Page 164, Figure 8-3: Change Low Iron Status to High Iron Status.
- Page 170, Table 8-20: Change Kayser-Fleischer rings to Toxicity column.
- Page 178, Table 8-28, Footnote b, Change to: An additional 12 mg zinc per liter of small bowel losses or 17 mg zinc per liter of stool or ileostomy losses may be needed
The A.S.P.E.N. Pediatric Support Core Curriculum, Second Edition
- Page 544, Table 32-13: Change Late Phase, red blood cell distribution width, increase.
- Page 563, Table 32-8: Change Schofield Equation, Females, >18 y: (13.623 × wt [kg]) + (2.83 × ht [cm]) + 98.2)
- To supplement book content, see the 2017 Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient
- Summary of 2017 Pediatric Guidelines
ASPEN Fluids, Electrolytes, and Acid-Based Disorders Handbook, Second Edition
- Page 29; Table 2-6, change to:
| Gatorade® G2 (ready to drink) + ½ teaspoon of salt b | 70 | 3.2 | 22.5 | 256 |
bGatorade® G2 (ready to drink) contains ~18.5 mEq of sodium per 32 ounces (946 mL). Addition of ½ teaspoon of salt to 32 ounces results in a sodium concentration of ~70 mEq/L; Potassium levels are well below the recommended amount for an ORS.
Nutrition-Focused Physical Exam for Adults: An Illustrated Handbook, Second Edition
- Page 3, Table 2-1: NUTRITION INTAKE AND WEIGHT-CHANGE ASSESSMENT: ASPEN–ACADEMY CLINICAL CHARACTERISTICS. In top “Malnutrition in the Context of Chronic Illness” column, under “Moderate (Nonsevere),” ≤75% should be <75%, and under “Severe,” <75% should be ≤75%.